お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は癌の分子バイオマーカー市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは癌の分子バイオマーカーの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の癌の分子バイオマーカー市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは癌の分子バイオマーカーのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に癌の分子バイオマーカー市場を分類しています。本研究に含まれる主な企業は：Correlogic Systems、AgendiaBv、BioMerieux、Aureon Laboratories、Astellas Pharma US、Becton、Diadexus、Abbott Laboratories、Affymetrix、Clarient、Biomoda、Beckman Coulter、Dickinson

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Genetic Methods
    Protein Methods
    Imaging

用途別の市場セグメント：
    Pharmaceutical
    Medical Laboratory
    Hospital

本レポートの詳細内容
世界の癌の分子バイオマーカー市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、癌の分子バイオマーカータイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の癌の分子バイオマーカー収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の癌の分子バイオマーカー市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、癌の分子バイオマーカー市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

癌の分子バイオマーカーのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：癌の分子バイオマーカーのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：癌の分子バイオマーカーの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章癌の分子バイオマーカー企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：癌の分子バイオマーカーの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：癌の分子バイオマーカーの主要企業の概要を提供し、製品の説明と仕様、癌の分子バイオマーカーの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological  process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments.
Market Analysis and Insights: Global Cancer Molecular Biomarkers Market
The global Cancer Molecular Biomarkers market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Factors such as technological advancements, increasing research and development activities, increase in funding from various government and non-government organizations, rise in healthcare expenditure, non invasive technology, increasing incidences of cancer, and streamlined drug delivery process are expected to drive the market for cancer molecular biomarkers .In addition, growing survival rates and increased accuracy of diagnosis with the help of biomarkers are expected to drive market for cancer molecular biomarkers.
Report Covers:
This report presents an overview of global market for Cancer Molecular Biomarkers market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Cancer Molecular Biomarkers, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Molecular Biomarkers, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Molecular Biomarkers revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cancer Molecular Biomarkers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cancer Molecular Biomarkers revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Correlogic Systems, AgendiaBv, BioMerieux, Aureon Laboratories, Astellas Pharma US, Becton, Diadexus, Abbott Laboratories and Affymetrix, etc.

Market Segmentation
By Company
    Correlogic Systems
    AgendiaBv
    BioMerieux
    Aureon Laboratories
    Astellas Pharma US
    Becton
    Diadexus
    Abbott Laboratories
    Affymetrix
    Clarient
    Biomoda
    Beckman Coulter
    Dickinson

Segment by Type
    Genetic Methods
    Protein Methods
    Imaging

Segment by Application
    Pharmaceutical
    Medical Laboratory
    Hospital

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer Molecular Biomarkers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Molecular Biomarkers companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Molecular Biomarkers revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Cancer Molecular Biomarkers Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Genetic Methods
    Table 3. Key Players of Protein Methods
    Table 4. Key Players of Imaging
    Table 5. Global Cancer Molecular Biomarkers Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Cancer Molecular Biomarkers Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Cancer Molecular Biomarkers Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Cancer Molecular Biomarkers Market Share by Region (2019-2024)
    Table 9. Global Cancer Molecular Biomarkers Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Cancer Molecular Biomarkers Market Share by Region (2025-2030)
    Table 11. Cancer Molecular Biomarkers Market Trends
    Table 12. Cancer Molecular Biomarkers Market Drivers
    Table 13. Cancer Molecular Biomarkers Market Challenges
    Table 14. Cancer Molecular Biomarkers Market Restraints
    Table 15. Global Cancer Molecular Biomarkers Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Cancer Molecular Biomarkers Revenue Share by Players (2019-2024)
    Table 17. Global Top Cancer Molecular Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Molecular Biomarkers as of 2023)
    Table 18. Global Cancer Molecular Biomarkers Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Cancer Molecular Biomarkers Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Cancer Molecular Biomarkers, Headquarters and Area Served
    Table 21. Global Key Players of Cancer Molecular Biomarkers, Product and Application
    Table 22. Global Key Players of Cancer Molecular Biomarkers, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cancer Molecular Biomarkers Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2019-2024)
    Table 26. Global Cancer Molecular Biomarkers Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2025-2030)
    Table 28. Global Cancer Molecular Biomarkers Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Cancer Molecular Biomarkers Revenue Share by Application (2019-2024)
    Table 30. Global Cancer Molecular Biomarkers Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Cancer Molecular Biomarkers Revenue Share by Application (2025-2030)
    Table 32. North America Cancer Molecular Biomarkers Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Cancer Molecular Biomarkers Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Cancer Molecular Biomarkers Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Cancer Molecular Biomarkers Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Cancer Molecular Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Cancer Molecular Biomarkers Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Cancer Molecular Biomarkers Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Cancer Molecular Biomarkers Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Cancer Molecular Biomarkers Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Cancer Molecular Biomarkers Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Cancer Molecular Biomarkers Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Cancer Molecular Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Cancer Molecular Biomarkers Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Cancer Molecular Biomarkers Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Cancer Molecular Biomarkers Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Cancer Molecular Biomarkers Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Cancer Molecular Biomarkers Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Cancer Molecular Biomarkers Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Cancer Molecular Biomarkers Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Cancer Molecular Biomarkers Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Cancer Molecular Biomarkers Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Cancer Molecular Biomarkers Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Cancer Molecular Biomarkers Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Cancer Molecular Biomarkers Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Cancer Molecular Biomarkers Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Correlogic Systems Company Details
    Table 65. Correlogic Systems Business Overview
    Table 66. Correlogic Systems Cancer Molecular Biomarkers Product
    Table 67. Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 68. Correlogic Systems Recent Developments
    Table 69. AgendiaBv Company Details
    Table 70. AgendiaBv Business Overview
    Table 71. AgendiaBv Cancer Molecular Biomarkers Product
    Table 72. AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 73. AgendiaBv Recent Developments
    Table 74. BioMerieux Company Details
    Table 75. BioMerieux Business Overview
    Table 76. BioMerieux Cancer Molecular Biomarkers Product
    Table 77. BioMerieux Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 78. BioMerieux Recent Developments
    Table 79. Aureon Laboratories Company Details
    Table 80. Aureon Laboratories Business Overview
    Table 81. Aureon Laboratories Cancer Molecular Biomarkers Product
    Table 82. Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 83. Aureon Laboratories Recent Developments
    Table 84. Astellas Pharma US Company Details
    Table 85. Astellas Pharma US Business Overview
    Table 86. Astellas Pharma US Cancer Molecular Biomarkers Product
    Table 87. Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 88. Astellas Pharma US Recent Developments
    Table 89. Becton Company Details
    Table 90. Becton Business Overview
    Table 91. Becton Cancer Molecular Biomarkers Product
    Table 92. Becton Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 93. Becton Recent Developments
    Table 94. Diadexus Company Details
    Table 95. Diadexus Business Overview
    Table 96. Diadexus Cancer Molecular Biomarkers Product
    Table 97. Diadexus Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 98. Diadexus Recent Developments
    Table 99. Abbott Laboratories Company Details
    Table 100. Abbott Laboratories Business Overview
    Table 101. Abbott Laboratories Cancer Molecular Biomarkers Product
    Table 102. Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 103. Abbott Laboratories Recent Developments
    Table 104. Affymetrix Company Details
    Table 105. Affymetrix Business Overview
    Table 106. Affymetrix Cancer Molecular Biomarkers Product
    Table 107. Affymetrix Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 108. Affymetrix Recent Developments
    Table 109. Clarient Company Details
    Table 110. Clarient Business Overview
    Table 111. Clarient Cancer Molecular Biomarkers Product
    Table 112. Clarient Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 113. Clarient Recent Developments
    Table 114. Biomoda Company Details
    Table 115. Biomoda Business Overview
    Table 116. Biomoda Cancer Molecular Biomarkers Product
    Table 117. Biomoda Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 118. Biomoda Recent Developments
    Table 119. Beckman Coulter Company Details
    Table 120. Beckman Coulter Business Overview
    Table 121. Beckman Coulter Cancer Molecular Biomarkers Product
    Table 122. Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 123. Beckman Coulter Recent Developments
    Table 124. Dickinson Company Details
    Table 125. Dickinson Business Overview
    Table 126. Dickinson Cancer Molecular Biomarkers Product
    Table 127. Dickinson Revenue in Cancer Molecular Biomarkers Business (2019-2024) & (US$ Million)
    Table 128. Dickinson Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Molecular Biomarkers Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Cancer Molecular Biomarkers Market Share by Type: 2023 VS 2030
    Figure 3. Genetic Methods Features
    Figure 4. Protein Methods Features
    Figure 5. Imaging Features
    Figure 6. Global Cancer Molecular Biomarkers Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Cancer Molecular Biomarkers Market Share by Application: 2023 VS 2030
    Figure 8. Pharmaceutical Case Studies
    Figure 9. Medical Laboratory Case Studies
    Figure 10. Hospital Case Studies
    Figure 11. Cancer Molecular Biomarkers Report Years Considered
    Figure 12. Global Cancer Molecular Biomarkers Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Cancer Molecular Biomarkers Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Cancer Molecular Biomarkers Market Share by Region: 2023 VS 2030
    Figure 15. Global Cancer Molecular Biomarkers Market Share by Players in 2023
    Figure 16. Global Top Cancer Molecular Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Molecular Biomarkers as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Cancer Molecular Biomarkers Revenue in 2023
    Figure 18. North America Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Cancer Molecular Biomarkers Market Share by Type (2019-2030)
    Figure 20. North America Cancer Molecular Biomarkers Market Share by Application (2019-2030)
    Figure 21. North America Cancer Molecular Biomarkers Market Share by Country (2019-2030)
    Figure 22. United States Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Cancer Molecular Biomarkers Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Cancer Molecular Biomarkers Market Share by Type (2019-2030)
    Figure 26. Europe Cancer Molecular Biomarkers Market Share by Application (2019-2030)
    Figure 27. Europe Cancer Molecular Biomarkers Market Share by Country (2019-2030)
    Figure 28. Germany Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Cancer Molecular Biomarkers Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Cancer Molecular Biomarkers Market Share by Type (2019-2030)
    Figure 36. China Cancer Molecular Biomarkers Market Share by Application (2019-2030)
    Figure 37. Asia Cancer Molecular Biomarkers Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Cancer Molecular Biomarkers Market Share by Type (2019-2030)
    Figure 39. Asia Cancer Molecular Biomarkers Market Share by Application (2019-2030)
    Figure 40. Asia Cancer Molecular Biomarkers Market Share by Region (2019-2030)
    Figure 41. Japan Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Cancer Molecular Biomarkers Market Share by Country (2019-2030)
    Figure 51. Brazil Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Cancer Molecular Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Correlogic Systems Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 58. AgendiaBv Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 59. BioMerieux Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 60. Aureon Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 61. Astellas Pharma US Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 62. Becton Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 63. Diadexus Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 64. Abbott Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 65. Affymetrix Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 66. Clarient Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 67. Biomoda Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 68. Beckman Coulter Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 69. Dickinson Revenue Growth Rate in Cancer Molecular Biomarkers Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed